Sage Journals: Discover world-class research

Retricted access

Other

First published 1999-7

Pharmaceutical Company Strategies for Designing Nonclinical Safety Programs for Products of Biotechnology

Susan A. Griffiths

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2019-7

Pharmaceutical interventions to improve safety of chemotherapy-treated cancer patients: A cross-sectional study

Johanne Daupin, Germain Perrin, Chloe Lhermitte-Pastor [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2013-4

Use of Animal Models of Human Disease for Nonclinical Safety Assessment of Novel Pharmaceuticals

Sherry J. Morgan, Chandikumar S. Elangbam, Shawn Berens [...]

Toxicologic Pathology

Open access

Research article

First published 2023

Risk control drives risk assessment and risk review: A cause and effect model of pharmaceutical drug recall on patient safety

Irene D Lin, John B Hertig

The Journal of Medicine Access

Retricted access

Other

First published 2009-9

Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety

Gretchen S. Dieck, Susan Betger, Daniel A. Kracov [...]

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2019-2

Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment–Opinion Paper

Masayuki Tomohiro, Takeshi Okabe, Yasushi Kimura [...]

Toxicologic Pathology

Free access

Research article

First published 2016-4

The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry

Curtis Colleton, David Brewster, Anne Chester [...]

Toxicologic Pathology

Retricted access

Research article

First published 1985-07

A Toxicology Databank Based on Animal Safety Evaluation Studies of Pharmaceutical Compounds

C.E. Lumley, S.R. Walker

Human & Experimental Toxicology

Free access

Research article

First published 1999-01

Safety Assessment of Biotechnology-Derived Pharmaceuticals: ICH and Beyond

Mercedes A. Serabian, Anne M. Pilaro

Toxicologic Pathology

Retricted access

Research article

First published 1998-02

Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an International Workshop

Susan A Griffiths, Cyndy E Lumley

Human & Experimental Toxicology

Search results